Actively Recruiting
3D-4K-ICG Laparoscopic Gastrectomy for Gastric Cancer
Led by Fujian Medical University · Updated on 2024-06-24
702
Participants Needed
1
Research Sites
312 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients with locally advanced gastric adenocarcinoma (CT2-4a N-/+ M0) were selected as study subjects to investigate the safety, efficacy, and feasibility of ICG near-infrared imaging tracing in 3D plus ultra high resolution laparoscopic gastrectomy with lymph node dissection for gastric cancer.
CONDITIONS
Official Title
3D-4K-ICG Laparoscopic Gastrectomy for Gastric Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age from 18 to 75 years
- Primary gastric adenocarcinoma confirmed by endoscopic biopsy (including papillary, tubular, mucinous, signet ring cell, or poorly differentiated types)
- Clinical stage cT2-4a, N-/+, M0 based on AJCC Cancer Staging Manual, 8th Edition
- No distant metastasis or direct invasion of pancreas, spleen, or other adjacent organs
- Eastern Cooperative Oncology Group performance status of 0 or 1
- American Society of Anesthesiology class I to III
- Provided written informed consent
You will not qualify if you...
- Women who are pregnant or breastfeeding
- Severe mental disorder
- History of previous upper abdominal surgery (except laparoscopic cholecystectomy)
- History of previous gastric surgery including ESD/EMR for gastric cancer
- Enlarged or bulky regional lymph node over 3 cm in diameter
- Other malignant diseases within the past 5 years
- Previous neoadjuvant chemotherapy or radiotherapy
- History of unstable angina or myocardial infarction within past six months
- History of cerebrovascular accident within past six months
- Continuous systemic corticosteroid use within one month
- Need for simultaneous surgery for other diseases
- Emergency surgery due to complications from gastric cancer such as bleeding, obstruction, or perforation
- Forced expiratory volume in one second (FEV1) less than 50% of predicted
- Diffuse invasive gastric cancer
- History of iodine allergy
- Patients who declined laparoscopic surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fujian Medical University Union Hospital
Fuzhou, Fujian, China, 350001
Actively Recruiting
Research Team
M
Mi Lin
CONTACT
H
Hua-Long Zheng
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here